Summary
The identification of several glycoconjugates as receptors for attaching bacteria has resulted in optimism regarding the use of receptor analogues in preventing infection. The structure of receptor-active oligosaccharides and the patient groups which might benefit from such treatment are most thoroughly understood for urinary tract infections. Prevention of adhesion and delay or decrease of infection was achieved using oligosaccharides from the globoseries of glycolipids containing Galα1→4Gal. This minimal receptor structure as a free saccharide was, however, not sufficient. It was the intact P, P1 and pk determinants which showed optimal activityin vitro. In addition, protection against experimental UTI results from previous exposure to whole bacteria or isolated antigens. The mechanism(s) of protection and their relevance in clinical UTI remain to be defined.
Zusammenfassung
Verschiedene Glykokonjugate wurden als Rezeptoren für anheftende Bakterien identifiziert; daher besteht Hoffnung auf die Anwendung von Rezeptoranaloga zur Infektionsverhütung. Die Strukturen der Rezeptor-wirksamen Oligosaccharide und Patientengruppen, die von einer solchen Therapie profitieren könnten, sind für Harnwegsinfektionen sorgfältig erforscht. Mit Oligosacchariden der Globoserie von Glykolipiden, die Galα 1→4Gal enthalten, ist es gelungen, das Anheften zu verhindern und die Infektion zu verzögern oder zu vermindern. Jedoch erwies sich diese minimale Rezeptorstruktur als freies Saccharid als nicht ausreichend.In vitro konnte vielmehr durch die intakten P-, P1- und pk-Determinanten eine optimale Wirkung erzielt werden. Eine Schutzwirkung vor experimenteller Harnwegsinfektion entsteht zusätzlich durch frühere Exposition gegenüber den kompletten Bakterien oder isolierten Antigenen. Auf welche Weise die Protektion zustande kommt und welche Bedeutung sie für klinische Harnwegsinfektionen hat, muß noch geklärt werden.
Literature
Kunin, C. M., Deutscher, R., Paquin, A. Urinary tract infection in school children: An epidemiologic, clinical and laboratory study. Medicine 43 (1964) 91–130.
Winberg, J., Andersson, H. J., Bergström, T., Jacobsson, B., Larsson, H., Lincoln, K. Epidemiology of symptomatic urinary tract infection in childhood. Acta Paediatr. Scand. Suppl. 252 (1974) 1–20.
Bergström, T., Lincoln, K., Ørskov, F., Ørskov, I., Winberg, J. Studies of urinary tract infections in infancy and childhood. VIII. Reinfection vs. relapse in recurrent urinary tract infecting organisms. J. Pediatr. 71 (1967) 13–20.
Hagberg, L., Engberg, I., Freter, R., Lam, J., Olling, S., Svanborg Edén, C. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenicEscherichia coli of human origin. Infect. Immun. 40 (1983) 273–283.
Korhonen, T. K., Leffler, H., Svanborg Edén, C. Specificity of the binding to epithelial cells, erythrocytes and yeast cells of piliated strains ofEscherichia coli andSalmonella typhimurium. Infect. Immun. 32 (1981) 796–804.
Svanborg Edén, C., Eriksson, B., Hanson, L. Å. Adhesion ofEscherichia coli to human uroepithelial cellsin vitro. Infect. Immun. 18 (1977) 767–774.
Leffler, H., Svanborg Edén, C. Chemical identification of a glycosphingolipid receptor forEscherichia coli attaching to human urinary tract epithelial cells and agglutinating of human erythrocytes. FEMS Microbiol. Lett. 8 (1980) 127–134.
Källenius, G., Möllby, R., Svensson, S. B., Winberg, J., Lundblad, A., Svensson, S. The pk antigen as receptor of pyelonephriticE. coli. FEMS Microbiol. Lett. 7 (1980) 297–302.
Duguid, J. P. The function of bacterial fimbriae. Arch. Imm. Ther. Exp. 16 (1968) 173–188.
Ørskov, I., Ørskov, F., Birch-Andersen, A. Comparison ofEscherichia coli fimbrial antigen F7 with type 1 fimbriae. Infect. Immun. 27 (1980) 657–666.
Marcus, D. M., Naiki, M., Kundu, S. K. Abnormalities in the glycosphingolipid content of human pk and p erythrocytes. Proc. Natl. Acad. Sci. USA 73 (1976) 3263–3267.
Kościelak, J., Miller-Podraza, H., Krauze, R., Cedergren, B. Glycolipid composition of blood P erythrocytes. FEBS Lett. 66 (1976) 250–253.
Breimer, M. E., Hansson, G. C., Karlsson, K. A., Leffler, H., Pimlott, W., Samuelsson, B. E. Selected ion monitoring of glycosphingolipid mixtures. Identification of several blood group type glycolipids in the small intestine of an individual rabbit. Biomed. Mass. Spectrom. 6 (1979) 231–241.
Engvall, E., Perlman, P. Enzyme-linked immunosorbent assay, ELISA III. Quantitation of specific antibodies by enzyme-labelled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 109 (1972) 129–135.
Ørskov, I., Ørskov, F. Serology ofEscherichia coli fimbriae. Progr. Allergy 33 (1982) 80–105.
Svanborg Edén, C., Fasth, A., Jodal, U. Immunology of urinary tract infection. In:Reeves, D. S., Geddes, A. M. (eds.): Recent advances in infection. Churchill Livingstone, London 1982, pp. 141–162.
Hunter, B. W., Akins, L. L., Sanford, J. P. The role of immunity in the pathogenesis of experimental retrograde pyelonephritis. J. Exp. Med. 119 (1964) 869–879.
Brooks, S. J. D., Lyons, J. M., Braude, A. I. Immunization against retrograde pyelonephritis. Am. J. Pathol. 74 (1974) 345–354.
Uehling, D. T., Mizutani, K., Balish, E. Effect of immunization on bacterial adherence to urothelium. Invest. Urol. 16 (1978) 145–147.
Kaijser, B., Larsson, P., Olling, S. Protection against ascendingEscherichia coli pyelonephritis in rats and significance of local immunity. Infect. Immun. 20 (1978) 78–81.
Kaijser, B., Larsson, P., Olling, S., Schneerson, R. Protection against acute ascending pyelonephritis caused byEscherichia coli in rats, conjugated to bovine serum albumin. Infect. Immun. 39 (1983) 142–146.
Layton, G. T., Smithyman, A. M. The effects of oral and combined parenteral/oral immunization against an experimentalEscherichia coli urinary tract infection in mice. Clin. Exp. Immunol. 54 (1983) 305–312.
Silverblatt, F., Cohen, S. Antipili antibody affords protection against experimental ascending pyelonephritis. J. Clin. Invest. 64 (1979) 333–336.
Svanborg Edén, C., Briles, D., Hagberg, L., McGhee, J., Michalec, S. Genetic factors in host resistance to urinary tract infections. Infection 12 (1984) 118–122.
Svanborg Edén, C., Eriksson, B., Hanson, L. Å., Jodal, U., Kaijser, B., Lidin-Janson, G., Lindberg, U., Olling, S. Adhesion to normal human uroepithelial cells ofEscherichia coli from children with various forms of urinary tract infection. J. Pediatr. 93 (1978) 398–403.
Freter, R. Studies of the mechanism of action of intestinal antibody in experimental cholera. Tex. Rep. Biol. Med. 27 Suppl. 1 (1969) 299–316.
Svanborg Edén, C., Svennerholm, A.-M. Secretory IgA and IgG prevent adhesion ofEscherichia coli to human urinary tract epithelial cells. Infect. Immun. 22 (1978) 790–797.
Svanborg Edén, C., Andersson, B., Leffler, H., Magnusson, G.: Binding to glycoconjugate receptors explaining the adhesion ofE. coli andS. pneumoniae. J. Dental Res. (in print).
Williams, R. C., Gibbons, R. J. Inhibition of bacterial adherence by secretory immunoglobulin A: A mechanism of antigenic disposal. Science 177 (1972) 697–699.
Svanborg Edén, C., Andersson, B., Hagberg, L., Hanson, L. Å., Lomberg, H., Leffler, H., Magnusson, G., Noori, G., Dahmén, J., Söderström, T. Receptor analogues and anti-pili antibodies as inhibitors of bacterial attachmentin vivo andin vitro. Proc. N. Y. Acad. Sci. 409 (1983) 580–592.
Svanborg Edén, C., Freter, R., Hagberg, L., Hull, R., Hull, S., Leffler, H., Schoolnik, G. Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue. Nature (London) 298 (1982) 560–562.
Källenius, G., Svensson, S. B., Hultberg, H., Möllby, R., Winberg, J., Roberts, J. A. P-fimbriae of pyelonephritogenicEscherichia coli: Significance for reflux and renal scarring. Infection 11 (1983) 73–76.
Svanborg Edén, C., Fasth, A., Hagberg, L., Hanson, L. Å., Korhonen, T., Leffler, H. Host interaction withEscherichia coli in the urinary tract. In:Robbins, J. B., Hill, J. C., Sadoff, J. C. (eds.): Seminars in infectious disease. Thieme Stratton Inc., New York 1982, pp. 113–131.
Svanborg Edén, C., Bjursten, L. M., Hagberg, L., Hull, R., Hull, S., Jodal, U., Leffler, H., Lomberg, H.: New aspects on pathogenesis and treatment of urinary tract infections, in relation to bacterial adherence. In:Losse, H., Lison, A. E. (eds.): Georg Thieme Verlag, Stuttgart (in print).
Leffler, H., Svanborg Edén, C. Glycolipid receptors for uropathogenicE. coli binding to human erythrocytes and uroepithelial cells. Infect. Immun. 34 (1981) 930–939.
Källenius, G., Möllby, R., Svensson, S. B., Helin, I., Hultberg, H., Cedergren, B., Winberg, J. Occurrence of P-fimbriatedEscherichia coli in urinary tract infections. Lancet II (1981) 1369–1372.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hagberg, L., Leffler, H. & Svanborg Edén, C. Non-antibiotic prevention of urinary tract infection. Infection 12, 132–136 (1984). https://doi.org/10.1007/BF01641697
Issue Date:
DOI: https://doi.org/10.1007/BF01641697